Role of vasodilator‐stimulated phosphoprotein in protein kinase A‐induced changes in endothelial junctional permeability
Authors:
Open Access
- 12 February 2002
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 16 (6) , 583-585
Abstract
At sites of ongoing inflammation, polymorphonuclear leukocytes (PMN, neutrophils) migrate across vascular endothelia, and such transmigration has the potential to disturb barrier properties and can result in intravascular fluid loss and edema. It was recently appreciated that endogenous pathways exist to dampen barrier disruption during such episodes and may provide an important anti‐inflammatory link. For example, during transmigration, PMN‐derived adenosine activates endothelial adenosine receptors and induces a cAMP‐dependent resealing of endothelial barrier function. In our study reported here, we sought to understand the link between cyclic nucleotide elevation and increased endothelial barrier function. Initial studies revealed that adenosine‐induced barrier function is tightly linked to activation of protein kinase A (PKA). Because PKA selectively phosphorylates serine and threonine residues, we screened zonula occludens‐1 (ZO‐1) immunoprecipitates for the existence of such phosphorylated proteins as targets for barrier regulation. This analysis revealed a dominantly phosphorylated band at 50 kDa. Microsequencing identified this protein as vasodilator‐stimulated phosphoprotein (VASP), an actin binding protein with multiple serine/threonine phosphorylation sites. Immunofluorescent microscopy revealed that VASP localizes to endothelial junctional complexes and colocalizes with ZO‐1, occludin, and junctional adhesion molecule‐1 (JAM‐1). To address the role of phospho‐VASP in regulation of barrier function, we generated a phosphospecific VASP antibody targeting the Ser157 residue phosphorylation site, the site preferred by PKA. Immunolocalization studies with this antibody revealed that upon PKA activation, phospho‐VASP appears at cell‐cell junctions. Transient transfection of truncated VASP fragments revealed a parallel increase in barrier function. Taken together, these studies reveal a central role for phospho‐VASP in the coordination of PKA‐regulated barrier function, such as occurs during episodes of inflammation.Keywords
Funding Information
- National Institutes of Health (DK50189, HL60569)
This publication has 62 references indexed in Scilit:
- Phosphorylation of the Vasodilator-stimulated Phosphoprotein Regulates Its Interaction with ActinJournal of Biological Chemistry, 2000
- Regulation of Human Endothelial Cell Focal Adhesion Sites and Migration by cGMP-dependent Protein Kinase IJournal of Biological Chemistry, 2000
- Characterization of the Interaction between Zyxin and Members of the Ena/Vasodilator-stimulated Phosphoprotein Family of ProteinsJournal of Biological Chemistry, 2000
- Putting on the Brakes: A Negative Regulatory Function for Ena/VASP Proteins in Cell MigrationCell, 2000
- Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?The Journal of Pathology, 2000
- Characterization of the actin binding properties of the vasodilator‐stimulated phosphoprotein VASPFEBS Letters, 1999
- PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membraneJournal of Clinical Investigation, 1999
- Protein phosphorylation regulated by cyclic nucleotide-dependent protein kinases in cell extracts and in intact human lymphocytesCellular Signalling, 1992
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityCell, 1991
- Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMPBiochemical and Biophysical Research Communications, 1990